-+ 0.00%
-+ 0.00%
-+ 0.00%

Genmab Reports Phase 3 Data Showing EPKINLY Combo Cuts Follicular Lymphoma Progression Risk by 79%

路透·12/07/2025 12:50:27

登錄查看新聞詳情